Training Pharmacokinetics — Compartmental Models & Drug Dosing IV Bolus & Oral Dosing — One-Compartment Model
1 / 2

IV Bolus & Oral Dosing — One-Compartment Model

60 min Pharmacokinetics — Compartmental Models & Drug Dosing

IV Bolus & Oral Dosing — One-Compartment Model

The one-compartment model treats the body as a single well-mixed compartment with volume $V_d$ (volume of distribution) and first-order elimination with rate constant $k_e$. This model, while simplistic, accurately describes the pharmacokinetics of many small-molecule drugs (aminoglycosides, vancomycin, digoxin) and forms the foundation for dosing interval calculations in clinical practice.

1. IV Bolus: Differential Equation and Solution

After instantaneous IV bolus of dose $D$, the plasma concentration $C(t)$ satisfies:

$$\frac{dC}{dt} = -k_e C, \quad C(0) = C_0 = D/V_d$$

Solution: $C(t) = C_0 e^{-k_e t}$. Key derived parameters:

  • Half-life: $t_{1/2} = \ln 2 / k_e = 0.693/k_e$
  • Clearance: $CL = k_e V_d$ (volume cleared per unit time, L/h)
  • AUC$_{0\to\infty}$: $\int_0^\infty C(t)\,dt = C_0/k_e = D/CL$

These three relationships — $C_0 = D/V_d$, $CL = k_e V_d$, $AUC = D/CL$ — are the PK holy trinity. Clearance is a physiological parameter (renal + hepatic clearance); $V_d$ reflects drug distribution in tissues.

2. Oral Dosing: First-Pass Effect & Bioavailability

Oral absorption follows first-order kinetics with rate constant $k_a$. The plasma concentration:

$$C(t) = \frac{F \cdot D \cdot k_a}{V_d(k_a - k_e)}\left(e^{-k_e t} - e^{-k_a t}\right)$$

where $F$ is the bioavailability (fraction of dose reaching systemic circulation). Peak concentration occurs at:

$$t_{max} = \frac{\ln(k_a/k_e)}{k_a - k_e}$$

$C_{max} = C(t_{max})$. AUC$_{oral} = FD/CL$ — the bioavailability $F$ scales the AUC; $F < 1$ due to incomplete absorption and first-pass hepatic metabolism. For drugs with high hepatic extraction (e.g., morphine, lidocaine, propranolol), $F = 1 - E_H$ where $E_H$ is the hepatic extraction ratio.

3. Multiple Dosing & Steady State

After $n$ doses at interval $\tau$, the trough concentration (just before the next dose) accumulates geometrically:

$$C_{trough,n} = C_{trough,1} \frac{1 - e^{-nk_e\tau}}{1-e^{-k_e\tau}}$$

Steady-state accumulation factor: $R_{acc} = 1/(1-e^{-k_e\tau})$. At steady state:

$$C_{ss,av} = \frac{FD}{CL \cdot \tau}, \quad C_{ss,max} = \frac{FD/V_d}{1-e^{-k_e\tau}} e^{-k_e t_{lag}}$$

Time to reach 99% of steady state $\approx 6.6 \times t_{1/2}$ — crucial for loading dose considerations in critical care (e.g., digoxin, aminoglycosides).

4. Nonlinear (Michaelis-Menten) Pharmacokinetics

Some drugs (phenytoin, ethanol, aspirin at high doses) saturate hepatic enzymes, exhibiting nonlinear (Michaelis-Menten) kinetics:

$$\frac{dC}{dt} = -\frac{V_{max}\cdot C}{K_m + C}$$

When $C \ll K_m$: pseudo first-order; when $C \gg K_m$: zero-order elimination (constant $V_{max}$ mg/h regardless of concentration). Small dose changes near $K_m$ produce disproportionately large changes in $C_{ss}$, explaining phenytoin's narrow therapeutic index.

Worked Example — Vancomycin Dosing

Patient: 70 kg, creatinine clearance 60 mL/min. Vancomycin PK: $V_d = 0.7 \times 70 = 49$ L, $CL = 0.06 \times 60 = 3.6$ L/h, $k_e = CL/V_d = 3.6/49 = 0.0735$ h$^{-1}$, $t_{1/2} = 0.693/0.0735 = 9.4$ h. For a target AUC/MIC = 400 (MIC = 1 mg/L): daily dose = $CL \times 400 = 3.6 \times 400 = 1440$ mg/day, given as 720 mg q12h. $R_{acc} = 1/(1-e^{-0.0735\times12}) = 1/(1-0.417) = 1.72$. ✓

One-Compartment IV Bolus PK Simulator
C₀ (peak) =?mg/L
t½ =?h
AUC =?mg·h/L
Clearance CL =?L/h

Practice Problems

1. Gentamicin is given as a 240 mg IV bolus. Population PK: $V_d = 18$ L, $k_e = 0.30$ h$^{-1}$. Compute $C_0$, $t_{1/2}$, $CL$, and AUC. If the MIC is 2 mg/L, at what time does the concentration fall to MIC?
2. An oral drug has $F = 0.65$, $k_a = 1.2$ h$^{-1}$, $k_e = 0.15$ h$^{-1}$, $V_d = 40$ L, $D = 100$ mg. Compute $t_{max}$, $C_{max}$, and AUC. How would $C_{max}$ change if the patient takes the drug with food (which reduces $k_a$ to 0.4 h$^{-1}$)?
3. Phenytoin has $V_{max} = 500$ mg/day, $K_m = 4$ mg/L. A patient is stable at 8 mg/L on 350 mg/day. A physician increases the dose to 400 mg/day. What new steady-state concentration do you predict? Comment on the clinical implications.